A b s t r a c t
I n t ro d u c t i o n
Drug therapies are the most common tre a tment in medical practice 1 . Drugs play an essential role in medical care and are used in virtually all medical specialties and for numero u s health conditions 2 . Medical pre s c riptions are thus important documents; they are instru ctions provided by pre s c ribers to dispensers and p a t i e n t s. Pre s c riptions summari ze the physic i a n's attitudes and expectations for the course of disease and the role drugs are expected to play in treatment 2 . Compliance with standard s for rational pre s c ription is thus a central part of health care. As a general policy for ra t i o n a l p re s c ription, the World Health Org a n i z a t i o n (WHO) 3 recommends establishing national s t a n d a rds focusing on quality of pre s c ri p t i o n data; evaluating data on drug use in medical and pharmaceutical practices and re p o rt i n g such information through a formal network ; and educational pro g rams for health care prof e s s i o n a l s. Drug use measurements have been applied as indicators of quality of pre s c ri b e r behavior and to accredit health care org a n i z ations by assessing optimal drug use 4 . Analysis of pre s c ription data could provide the basis for reviewing pre s c ription practices and deve lo ping measures to promote the rational use of d rugs and pre vent dru g -related problems 5 . Acc o rding to the WHO 6 , the rational use of dru g s re q u i res that patients re c e i ve medications ap-p ro p riate to their clinical needs, in doses that meet their own individual re q u i re m e n t s, for an adequate period of time, and at the lowest cost to them and their community.
Studies on pre s c ription are included among Drug Utilization Studies (DUS), which enable identification and analysis of problems re l a t e d to drug use and their causes and consequences, establishing a more rational basis for solutions and assessment of subsequent actions 7 . St u dies on pre s c ription can be designed to achieve s e ve ral objectives: to describe current tre a tment practices; to compare pre s c ription proc e d u res among similar institutions; to re g u l a rly monitor and supervise the pro c e d u res during the pre s c ription and use of drugs; and to assess the results of an intervention designed to change the pre s c ribing process 8 .
Most studies on drug thera py and drug prescribing have been conducted in primary health c a re settings in developing countries and have s h own that practitioners tend to pre s c ribe too many drugs and ones that are too fre q u e n t l y i n e f f e c t i ve 9 . Most countries often have to ra t i on a l i ze the use of medications and develop stra t egies to improve compliance and promote prim a ry pre vention 1 0 . Ac c o rding to Ca s t ro et al. 1 1 , t h e re has been a growing number of DUS in Brazil, addressing re l e vant public health aspects and providing useful knowledge to change the observed re a l i t y. The authors highlight some studies that address quality of medical pre s c ription in Brazil, namely studies on the quality of outpatient pre s c ri ption of benzo d i a zepines and nonsteroidal anti-i n f l a m m at o ry drugs in adults 1 2 ; assessment of quality of medical pre s c ription and drug use profiles in the hospital environment 1 3 ; perception of pres c ri p t i o n -related problems by pharm a c y school underg raduate students 1 4 ; and eva l u ation of factors influencing pre s c ription of medicines for diarrhea in children 1 5 .
In Belo Ho ri zo n t e, Du t ra et al. 1 6 a n a l y ze d aspects of outpatient pre s c ription and dispensing of diazepam, and Castilho et al. 1 7 s t u d i e d the pre s c ription pattern of systemically used a n t i m i c robial and analgesic/anti-inflammatory drugs in dental pra c t i c e.
Gi ven that pre s c ription analysis prov i d e s some of the most accurate indicators of medical knowledge and quality of health services 1 8 , and considering organizational conditions, this paper aims to analyze drug pre s c riptions filled at health center dispensaries under the Mu n i cipal Health De p a rtment in Belo Ho ri zo n t e.
Re c e n t l y, there has been a significant inc rease in the consumption of medicines thro u g h Municipal Health De p a rtment health centers. Although the budget of this De p a rtment for p u rchase of medicines has increased since 1996, it has not been sufficient to fully supply the system's demands. In addition, the lack of c ri t e ria and suitable instruments to contro l the f l ow of medicines in health centers makes m o n i t o ring of consumption impossible. It thus became evident that standard i zed pro c e d u re s among health departments we re necessary to e n s u re access by the population to medicines in a rational and org a n i zed fashion. In 1998, the Municipal Health De p a rtment issued an a d m i n i s t ra t i ve ruling for this purpose and re commended that pre s c riptions be filled out in d u p l i c a t e. One copy of the pre s c ription was kept in the service as evidence of dispensation. Ap a rt from the administra t i ve aspect, this p rocess facilitated drug surveillance and dru g use studies. A previous study conducted at health centers under the Municipal Health Dep a rtment had already indicated some pre s c ri bing problems related to dosage and duration of t reatment with diazepam 1 6 . The present study attempted to expand the knowledge on quality of medical pre s c riptions in these serv i c e s, aimed at establishing information and educational measures to help optimize tre a t m e n t .
Material and methods
Belo Ho ri zonte is the third largest city in Bra z i l , with approximately 2.2 million inhabitants. It is divided into nine political and administrat i ve are a s. T h e re is a health department in each a d m i n i s t ra t i ve area to manage its own health s e rv i c e s. The technical coordination of health d e p a rtments is centra l i zed in the Mu n i c i p a l Health De p a rtment of Belo Ho ri zo n t e, Mi n a s Ge ra i s, Bra z i l .
The Municipal Health De p a rtment includes 126 health centers with similar chara c t e ri st i c s. This study was carried out in a sample of 63 randomly selected centers. Field work was done from Ma rch 1 to Ap ril 15, 1999, and each s e rvice was investigated for one week. All pres c riptions containing at least one of the eight selected drugs (medrox y p ro g e s t e rone acetate, a m i t ri p t y l i n e, carbamaze p i n e, glibenclamide, h a l o p e ridol, insulin, methyldopa, and nifedipine) and dispensed at these services duri n g this p e riod we re collected and included in the s t u d y. These drugs we re selected due to their i n c reased consumption in previous years and to institutional interest in pharm a c o t h e rap e utic aspects of their use, such as inappro p riate selection of medicines, inadequate dosage s c h e d u l e, and duration of treatment, exc e ss i ve number of drugs per pre s c ription leading to increased risk of drug interactions and adverse re a c t i o n s, and lack of re c o m m e n d a t i o n s for use. These pharm a c o t h e rapeutic issues are the object of other specific studies and will not be addressed in this art i c l e. The present study will focus on features related to quality of these p re s c riptions in the sample.
Two groups of pre s c riptions we re established by origin. One group consisted of internal pre s c riptions from the Municipal He a l t h De p a rtment health centers, filled out in the Se rvice form. The other group consisted of p res c riptions filled out by physicians from other public health centers, pri vate centers, and c h a ritable serv i c e s.
After a training pro g ram, data we re gathe red using a previously tested standard i ze d f o rm. An instruction manual was pre p a red to guide the data collection pro c e s s. Eight pharmacists we re responsible for the data collection. Data we re gathered in copies of pre s c ri ptions filed during the dispensing process at each health center during the study period.
Legal and general aspects of pre s c ri p t i o n s we re taken into account, in accordance with Brazilian legislation 1 The following cri t e ria we re established for data collection and analysis:
• The va riable Date was considered present if month, day, and year we re re c o rd e d ; • As to dosage regimen, the following we re c o n s i d e red: (a) Ad m i n i s t ration ro u t e was pre s e n t when the following expressions we re re c o rd e d : o ral, sublingual, intra ve n o u s, intra m u s c u l a r, p re ssions such as "continuous use" or "used as dire c t e d" we re not allowed, because they potentially induce patients to believe they can use the p re s c ription for an indefinite period, with no medical follow-up or adequate control; and (d) illegible information was classified as absent.
• Fixed-dose combinations we re considere d as one single dru g ; • Generic name: Brazilian Common Na m e s enacted by an administra t i ve ruling we re used as the re f e re n c e. Although not included in this list, NPH insulin and nifedipine we re allowe d because of their widespread usage; • Selected drug: the List of Selected Dru g s adopted by the Municipal Health De p a rt m e n t was used as the re f e re n c e. This list included 192 dru g s, of which 67.2% we re included in the National List of Essential Drugs (RENAME);
• T h ree categories we re established to summari ze the results related to the drugs pre s c ri b e d : all drugs -all drugs pre s c ribed presented the c h a ra c t e ristic studied; some drugs -at least one of the drugs pre s c ribed presented the chara c t e ristic studied; no drugs -none of the drugs pres c ribed presented the chara c t e ristic studied.
Ep i Info version 6 .04 was used to analyze the percentage differences between intern a l and external pre s c ri p t i o n s. Chi-square test was conducted with a p value of 0.05.
R e s u l t s
This study included 2,207 internal and 2,400 e x t e rnal pre s c ri p t i o n s. The majority (70.9%) of e x t e rnal pre s c riptions we re from pri vate health s e rv i c e s.
As for pre s c riber data and legibility of pres c ription, more than 90% of the pre s c ri p t i o n s contained the information re q u i red by law: Si gn a t u re , Legible name, Regional Medical Bo a rd Re g i s t ration Nu m b e r, and Da t e. The re s u l t s we re similar for internal and external pre s c ri p-tions ( Table 1) . Most drugs we re legibly pres c ribed in both groups (internal = 97.3%; external = 98.3%). Table 2 shows the percentage of dosage re gimen re c o rded in the pre s c ri p t i o n s. Mo re than 95% of both internal and external pre s c ri p t i o n s s h owed Do s a g e and Fre q u e n c y for all drugs pres c ribed. Do s a g e , Fre q u e n c y, and Du ration of t reatment we re specified more frequently in int e rnal pre s c ri p t i o n s. On the other hand, Adm i n i s t ration ro u t e , Pharmaceutical form, and Units of measure we re specified more re g u l a rly in external pre s c ri p t i o n s. Du ration of t re a tment was considerably more frequent on internal pre s c riptions (75.1%) as compared to external pre s c riptions (58.6%). This could be re l a t e d to public health service guidelines that re q u i re re c o rding this information. A certain perc e n tage in both groups of pre s c riptions failed to specify the Pharmaceutical form (in 30.9% of i n t e rnal pre s c riptions and 29.8% of extern a l p re s c riptions). Similar results we re found for Units of measure (28.1% of internal and 20.3% of external pre s c ri p t i o n s ) . Table 3 shows the re c o rding of pre s c ri b e d q u a n t i t y. Pre s c riptions showing quantities pres c ribed for all drugs corresponded to 69.7% of i n t e rnal and 57.8% of external pre s c ri p t i o n s. T h e re was no information on quantity in 19.3% of internal and 32.6% of external pre s c ri p t i o n s (χ 2 2gl = 106.17 and p = 0.000). Table 4 shows the total number of drugs per p re s c ription. Most pre s c riptions (72%) in both g roups included up to three dru g s. Pre s c ri ptions with only one drug we re more frequent in the external gro u p, demonstrating a statistically significant difference (χ 2 3gl = 10.37 and p = 0.016). The mean number of drugs per pres c ription was 2.4 in both gro u p s. Table 5 displays the use of generic names in p re s c ri p t i o n s. In t e rnal pre s c riptions contained the generic name more often (51.9%) than ext e rnal pre s c riptions (28.4%) (χ 2 2 g l = 347.18 and p = 0.000). Ex t e rnal pre s c riptions with no g e n e ric name we re approximately twice as frequent as for internal pre s c ri p t i o n s.
Focusing on pre s c ription of selected dru g s, we observed that all the drugs pre s c ribed we re included in the Municipal Health De p a rt m e n t's List of Selected Drugs in 88.7% of the intern a l and 76.4% of the external pre s c riptions (Ta b l e 6). T h e re was a statistically significant difference between the two groups (χ 2 2gl = 118.30 and p = 0.000). Howe ve r, only 49.8% of intern a l and 47.9% of external pre s c riptions we re fully d i s p e n s e d .
Ve ry few pre s c riptions met all the selected recommendations for drug use (Table 7) . So m e Table 1 P resence of prescriber data and date, by origin of prescription.
Belo Horizonte, Minas Gerais, Brazil, 1999.
Va r i a b l e P rescription (%) I n t e rnal (n = 2,207) E x t e rnal (n = 2,400)
S i g n a t u re 9 8 . 6 9 8 . 8
Legible name 9 3 . 2 9 4 . 7
Physician registration number 9 3 . 6 9 4 . 3 D a t e 9 5 . 3 9 4 . 4 Table 2 R e c o rd of dosage regimen for drugs prescribed by origin of prescription.
Va r i a b l e s P re s c r i p t i o n* I n t e rn a l E x t e rn a l 84.3% of internal and 85.5% of external pres c riptions had no recommendations for use.
D i s c u s s i o n
The results of this study allowed for an assessment of pre s c ription orders dispensed at Municipal Health De p a rtment centers in Belo Ho ri zo n t e. Guidelines and recommendations provided in both the litera t u re and the pert i n e n t legislation we re not properly complied with, which could lead to errors in both dispensation and drug use. By and larg e, the indicators d e m o n s t rated more favo rable results in internal pre s c ri p t i o n s. Howe ve r, some problems related to quality we re observed in both types of p re s c ri p t i o n s.
Completeness of p rescriber data and d a t e i n f o rmation we re high in both gro u p s, although insufficient considering the Mu n i c i p a l Health De p a rtment guidelines, which forbid dispensing drugs with pre s c riptions that do not contain these data. Incomplete pre s c ri ptions indicate problems in linkage betwe e n p re s c ription and dispensation in the serv i c e s. Mo re ove r, these data are re q u i red by law and can be used if further contact with the pres c riber is needed for clarification 2 1 . Likewise, illegible pre s c riptions are still found, although they are obviously incompatible with both p roper dispensation and usage. Legible pres c ribing is a legal responsibility and is fundamental for avoiding errors in dispensation and d rug use.
Co n s i d e ring dosage regimen, data concerning a d m i n i s t ration ro u t e , pharmaceutical form, units of measure , a n d d u ration of tre a t m e n t we re absent from numerous pre s c riptions in both gro u p s. These data are essential for pres c riptions to provide key information about t reatment, fostering suitable dispensation and i n c reased treatment compliance. The re s u l t s clearly demonstrate that an educational intervention is needed to raise the awareness of pres c ribers concerning the importance of re c o rding this information 2 2 , 2 3 .
The ave rage number of drugs per pre s c ri ption is used as an indicator to determine the level of polypharm a c y. The use of multiple dru g s to treat the same condition is extremely common and has been associated with adverse rea c t i o n s, medication erro r s, and increased ri s k of hospitalization 2 4 . This study demonstra t e d an ave rage of 2.4 drugs per pre s c ription, an int e rmediate result in comparison to other studies carried out in Brazil (ranging from 1.8 to 3.0 d rugs per pre s c ription) 2 5 , 2 6 as well as in other Table 3 P rescriptions with specification of quantity of drug prescribed, by origin of prescription. Belo Horizonte, Minas Gerais, Brazil, 1999.
P rescription (%)
χ 2 2 g l p* I n t e rn a l E x t e rnal (n = 2,207) (n = 2,400)
All drugs 6 9 . 7 5 7 . 8 1 0 6 . 1 7 0 . 0 0 0 Some drugs 1 1 . 0 9 . 5
No drugs 1 9 . 3 3 2 . 7
* statistically significant Table 4 Total number of drugs per prescription* by origin of prescription.
Number of drugs P rescription (%) χ 2 3 g l p*
I n t e rnal E x t e rn a l (n = 2,207) (n = 2,400)
O n e 2 7 . 5 3 1 . * mean number of drugs per prescription = 2.4 (for both gro u p s ) ** statistically significant Table 5 Drugs prescribed by generic name, by origin of prescription.
P rescription (%) χ 2 2 g l p* I n t e rnal E x t e rnal (n = 2,207) (n = 2,400) c o u n t ri e s, ranging from 1.4 to 2.8 2 2 , 2 3 . Co n s i de ring that the more the drugs pre s c ribed, the m o re likely the drug intera c t i o n s, and that a maximum of three drugs is recommended, the a ve rage number shown in this study can be c o n s i d e red satisfactory. The use of generic names was re l a t i vely low and was observed more often in internal pres c riptions (that is, pre s c riptions ori g i n a t i n g inside the Municipal health centers). Anothe r study in Brazil 2 5 re p o rted the re c o rding of g e n e ric names on pre s c riptions in 32.7% to 81.0% of cases. Use of generic names is re c o mmended by the WHO and re g a rded as an imp o rtant factor for promoting rational use of d ru g s. Fu rt h e rm o re, the use of generic names contributes to cost reduction and provides more a l t e rn a t i ves for drug purc h a s e s. The use and a d vantages of generic names have been widely discussed in seve ral studies 3 , 2 0 , 2 5 . Although the p resent study shows a greater trend tow a rd s use of generic names in internal pre s c ri p t i o n s, the results are still not satisfactory, since acc o rding to Brazilian law, all pre s c riptions filled out at Unified Health System (SUS) units should contain the generic name. The inconsistent use of generic names could be explained by the fact that pre s c ription using the brand name is highly influenced by marketing strategies deve loped by the pharmaceutical industry and targeted at physicians. Such strategies focus more a g g re s s i vely on the pri vate sector; howe ve r, many Brazilian physicians work in both public health services and in pri vate practice and are t h e re f o re prone to such influence.
Both groups displayed a high percentage of p re s c riptions containing only drugs included on the Municipal Health De p a rt m e n t's List of Selected Dru g s. Another study in Brazil 2 6 rep o rted pre s c ription of selected drugs ra n g i n g f rom 44.8% to 89.5%. The results observed in this study may indicate that the Municipal Dru g List meets the needs of the population or that physicians choose the selected drugs due to their availability at Municipal Health De p a rtment units. Although 82.6% of the pre s c ri p t i o n s a n a l y zed presented only drugs included on the Municipal Drug List, we observed that only 48.3% of them we re completely dispensed. T h i s result may be associated with the irregular supply experienced by the service during the early months of 1999. This situation demonstra t e s the need to implement mechanisms to ensure regular inve n t o ry and distribution of selected d rugs to municipal services in order to avo i d c o n s t rained demand.
The high percentage of lack of inform a t i o n on recommendations for use in pre s c ri p t i o n s is also a worrisome factor in both gro u p s. Ins t ructions for use are an essential part of pres c riptions and should be written in legible, obj e c t i ve, and accurate fashion 2 1 . Such inform ation can influence treatment compliance and should be written on the pre s c ription and explained verbally during the appointment. T h e main objective of these recommendations is to e n s u re safe use of medication and there f o re f e wer complications and adverse eve n t s.
This study has some limitations: it was res t ricted to health care services under the Municipal Health De p a rtment of Belo Ho ri zo n t e, included only eight products from the Mu n i c ipal Drug List, and did not assess pharm ac o t h e rapeutic aspects of pre s c ription. Ne ve rt h e l e s s, identifying some features of pre s c ri ptions dispensed at health center pharm a c i e s under the Municipal Health De p a rtment highlighted the need to implement actions for better quality provision. T h u s, such chara c t e ri s t i c s could be useful for orienting measures aimed at the rational use of drugs in municipal services and evaluation of future interve n t i o n s.
The process of properly selecting and pres c ribing drugs for each individual patient has Table 6 Selected drugs prescribed by origin of prescription.
All drugs 8 8 . Table 7 Recommendations for usage, by origin of prescription.
P rescription (%) χ 2 2 g l p* I n t e rnal E x t e rnal (n = 2,207) (n = 2,400) 
